Context Therapeutics SG&A Expense (Quarterly) Trends

Context Therapeutics Inc (CNTX)

1.86 +0.01 (+0.54%) USD | NASDAQ | Sep 27, 16:00

1.85 -0.01 (-0.54%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	1.704M
March 31, 2024	1.850M
December 31, 2023	1.631M
September 30, 2023	1.695M
June 30, 2023	1.831M
March 31, 2023	2.132M
December 31, 2022	1.738M
September 30, 2022	1.970M
June 30, 2022	1.991M

Date	Value
March 31, 2022	2.092M
December 31, 2021	1.798M
September 30, 2021	0.8285M
June 30, 2021	0.6046M
March 31, 2021	0.4016M
December 31, 2020	0.1747M
September 30, 2020	0.1824M
June 30, 2020	0.2854M
March 31, 2020	0.2882M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.1747M

Minimum

Dec 2020

2.132M

Maximum

Mar 2023

1.289M

Average

1.700M

Median

SG&A Expense (Quarterly) Benchmarks